Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

101.60 -0.35 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 835,350
Open 97.89
Bid (Size) 98.00 (1)
Ask (Size) 103.00 (1)
Prev. Close 101.95
Today's Range 97.89 - 103.42
52wk Range 25.32 - 117.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why GeneDx Holdings Stock Crushed It Again Today
It continued to ride high on its solid second-quarter performance. 
Via The Motley Fool
What 4 Analyst Ratings Have To Say About GeneDx Holdings
 
Via Benzinga

Performance

YTD
+27.6%
+27.6%
1 Month
+13.2%
+13.2%
3 Month
+51.1%
+51.1%
6 Month
+35.7%
+35.7%
1 Year
+215.0%
+215.0%

More News

Read More
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why GeneDx Holdings Stock Blasted 8% Higher Today
Via The Motley Fool
Earnings Scheduled For July 29, 2025
Via Benzinga
Exploring GeneDx Hldgs's Earnings Expectations
Via Benzinga
Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Technical Strength for Potential Upside
Via Chartmill
GeneDx CFO Sells More Than Half of His Shares
Via The Motley Fool
Topics Artificial Intelligence
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of CTO Realty, GeneDx, Quantum, and Proficient Auto and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of PetMed, GeneDx, Lineage, and Proficient Auto and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
From GeneDx
Via Business Wire
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
Via MarketBeat
Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts
Via Benzinga
Why GeneDX Stock Surged Higher This Week
Via The Motley Fool

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 101.60
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 08/01/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.